Safety of and Immune Response to a New HIV Vaccine: HIV CTL MEP

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00076037
Recruitment Status : Completed
First Posted : January 14, 2004
Last Update Posted : March 5, 2015
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)